Anyone who gets Covid19-related pneumonia will generally be treated with an iv immunoglobulin (Ig) infusion. This is CSL's main product line, accounting for more than 40% of revenue.
CSL Chart, page-762
-
- There are more pages in this discussion • 348 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$283.99 |
Change
-2.670(0.93%) |
Mkt cap ! $137.3B |
Open | High | Low | Value | Volume |
$285.50 | $285.81 | $282.18 | $44.99M | 158.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $283.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$283.99 | 23 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 24 | 283.940 |
2 | 12 | 283.920 |
1 | 25 | 283.910 |
1 | 8 | 283.900 |
1 | 25 | 283.870 |
Price($) | Vol. | No. |
---|---|---|
283.970 | 28 | 1 |
283.980 | 9 | 1 |
283.990 | 44 | 3 |
284.000 | 25 | 1 |
284.010 | 54 | 6 |
Last trade - 14.40pm 13/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online